Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)".
Carlo CattriniCarlo MessinaAlessia MennittoMassimo Di MaioAlessandra GennariDavid OlmosPublished in: International journal of cancer (2022)